标题
Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions
作者
关键词
Melanoma, Metastatic Melanoma, Objective Response Rate, BRAF Mutation, Ipilimumab
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 14, Issue 3, Pages 179-194
出版商
Springer Nature
发表日期
2013-05-15
DOI
10.1007/s40257-013-0025-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma.
- (2017) A. Ribas et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical Management of Solitary Metastatic Melanoma
- (2016) A.L. Komorowski et al. ACTA CHIRURGICA BELGICA
- Management of Malignant Melanoma: Best Practices
- (2015) Michael Smylie et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- CD69+CD4+CD25- T Cells, a New Subset of Regulatory T Cells, Suppress T Cell Proliferation through Membrane-Bound TGF- 1
- (2014) Y. Han et al. JOURNAL OF IMMUNOLOGY
- Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
- (2014) S. Adams et al. JOURNAL OF IMMUNOLOGY
- Melanoma: Are we there yet?
- (2014) Donald L. Morton JOURNAL OF SURGICAL ONCOLOGY
- Rationale for complete metastasectomy in patients with stage IV metastatic melanoma
- (2012) David W. Ollila et al. JOURNAL OF SURGICAL ONCOLOGY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
- (2012) Joannes FM Jacobs et al. LANCET ONCOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
- (2011) R. von Moos et al. ANNALS OF ONCOLOGY
- Targeting Metastatic Melanoma
- (2011) Keith T. Flaherty Annual Review of Medicine
- Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma
- (2011) Sucheta Telang et al. BMC CANCER
- A phase 2 trial of complete resection for stage IV melanoma
- (2011) Jeffrey A. Sosman et al. CANCER
- Combination of targeted therapy and immunotherapy in melanoma
- (2011) Christian U. Blank et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cytotoxic T-Lymphocyte-Associated Antigen-4
- (2011) A. K. S. Salama et al. CLINICAL CANCER RESEARCH
- New Strategies in Metastatic Melanoma: Oncogene-Defined Taxonomy Leads to Therapeutic Advances
- (2011) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
- (2011) James S. Wilmott et al. CLINICAL CANCER RESEARCH
- Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma
- (2011) J. M. Kirkwood et al. CLINICAL CANCER RESEARCH
- Current Surgical Treatment in Melanoma
- (2011) Mark B. Faries et al. CURRENT PROBLEMS IN CANCER
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma
- (2011) Kevin B. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma
- (2011) Valerie P. Grignol et al. JOURNAL OF IMMUNOTHERAPY
- Surgical management of melanoma brain metastases in patients treated with immunotherapy
- (2011) Russell R. Lonser et al. JOURNAL OF NEUROSURGERY
- Does metastasectomy improve survival in patients with stage IV melanoma? a cancer registry analysis of outcomes
- (2011) Nabil Wasif et al. JOURNAL OF SURGICAL ONCOLOGY
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
- (2011) C. Garbe et al. ONCOLOGIST
- Effectiveness of Carboplatin and Paclitaxel as First- and Second-Line Treatment in 61 Patients with Metastatic Melanoma
- (2011) Annette Pflugfelder et al. PLoS One
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Survival after Pulmonary Metastasectomy in Patients with Malignant Melanoma
- (2011) C. Schuhan et al. THORACIC AND CARDIOVASCULAR SURGEON
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- (2010) S. J. O'Day et al. ANNALS OF ONCOLOGY
- Using genetics and genomics strategies to personalize therapy for cancer: Focus on melanoma
- (2010) Katherine L. Nathanson BIOCHEMICAL PHARMACOLOGY
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma
- (2010) Lisa A. Kottschade et al. CANCER
- Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
- (2010) J. F. M. Jacobs et al. CLINICAL CANCER RESEARCH
- Mutation-driven drug development in melanoma
- (2010) Keith T Flaherty et al. CURRENT OPINION IN ONCOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide
- (2010) C. Kim et al. ONCOLOGIST
- Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells
- (2010) C. Krieg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metastasectomy for Stage IV Melanoma: For Whom and How Much?
- (2010) Abigail S. Caudle et al. Surgical Oncology Clinics of North America
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Integrating BRAF/MEK inhibitors into combination therapy for melanoma
- (2009) K S M Smalley et al. BRITISH JOURNAL OF CANCER
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
- (2009) J. Weber et al. CLINICAL CANCER RESEARCH
- Surgical Treatment of Advanced Melanoma
- (2009) Christopher J. Hussussian CLINICS IN PLASTIC SURGERY
- Surgical Management of Melanoma
- (2009) Jennifer A. Wargo et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
- (2009) Maria A. Curotto de Lafaille et al. IMMUNITY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients
- (2009) Michal J. Besser et al. JOURNAL OF IMMUNOTHERAPY
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
- (2009) Todd D Prickett et al. NATURE GENETICS
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- Factors affecting the outcome after treatment for metastatic melanoma to the brain
- (2009) Christopher J. Carrubba et al. SURGICAL NEUROLOGY
- Melanoma adrenal metastasis: natural history and surgical management
- (2008) Elizabeth A. Mittendorf et al. AMERICAN JOURNAL OF SURGERY
- Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 Overexpression
- (2008) K. S.M. Smalley et al. CANCER RESEARCH
- BRAF V600E Disrupts AZD6244-Induced Abrogation of Negative Feedback Pathways between Extracellular Signal-Regulated Kinase and Raf Proteins
- (2008) B. B. Friday et al. CANCER RESEARCH
- A rational surgical approach to the treatment of distant melanoma metastases
- (2008) Steve R. Martinez et al. CANCER TREATMENT REVIEWS
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
- Surgery for melanoma metastases of the gastrointestinal tract: Indications and results
- (2008) A. Sanki et al. EJSO
- Improved Survival After Lymphadenectomy for Nodal Metastasis From an Unknown Primary Melanoma
- (2008) Chris C. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma
- (2008) Jeffrey A. Sosman et al. JOURNAL OF CLINICAL ONCOLOGY
- Major Response to Imatinib Mesylate in KIT-Mutated Melanoma
- (2008) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
- (2008) Michael B. Atkins et al. JOURNAL OF CLINICAL ONCOLOGY
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Can surgeons improve survival in stage IV melanoma?
- (2008) Paul J. Mosca et al. JOURNAL OF SURGICAL ONCOLOGY
- Transient T cell depletion causes regression of melanoma metastases
- (2008) Mary Rasku et al. Journal of Translational Medicine
- Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients
- (2008) Francesca Tauceri et al. LANGENBECKS ARCHIVES OF SURGERY
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- Long-Term Survival in Stage IV Melanoma after Repetitive Surgical Therapy
- (2008) Tsvetomir Tomov et al. ONKOLOGIE
- Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF
- (2008) Claudia Wellbrock et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now